R A Reisfeld1, S D Gillies. Show Affiliations » 1. Scripps Research Institute, La Jolla, CA 92037, USA.
Abstract
Entities: Disease
Mesh： See more » AnimalsAntibodies, Neoplasm/geneticsAntibodies, Neoplasm/therapeutic useAntibody-Dependent Cell CytotoxicityCytokines/geneticsCytokines/pharmacokineticsCytokines/therapeutic useEpidermal Growth Factor/geneticsEpidermal Growth Factor/immunologyHumansImmunoconjugates/geneticsImmunoconjugates/immunologyImmunoconjugates/therapeutic useImmunotherapy, AdoptiveInterleukin-2/geneticsInterleukin-2/therapeutic useKiller Cells, Lymphokine-Activated/immunologyKiller Cells, Lymphokine-Activated/transplantationLymphotoxin-alpha/geneticsLymphotoxin-alpha/therapeutic useMiceMice, SCIDNeoplasm TransplantationNeoplasms/immunologyNeoplasms/therapyNeuroblastoma/secondaryNeuroblastoma/therapyRecombinant Fusion Proteins/immunologyRecombinant Fusion Proteins/pharmacokineticsRecombinant Fusion Proteins/therapeutic useSuperantigens/geneticsSuperantigens/immunologyT-Lymphocytes, Cytotoxic/immunology
Substances： See more » Antibodies, NeoplasmCytokinesImmunoconjugatesInterleukin-2Lymphotoxin-alphaRecombinant Fusion ProteinsSuperantigensEpidermal Growth Factor
Year: 1996 PMID： 8815009 DOI： 10.1007/978-3-642-80071-9_3
Source DB: PubMed Journal: Curr Top Microbiol Immunol ISSN： 0070-217X Impact factor: 4.291